๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Biliary Tract Cancer (BTC)

Histotripsy in Biliary Tract Cancer NCT07853690NA1 site๐Ÿ“ New York NYU Langone Health ยท Tests: Gemcitabine, Cisplatin, Durvalumab, Pembrolizumab, Histotripsy Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) NCT06564623Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: mBTC vax [0.3 - 2.4 mg peptide + 0.5 mg Poly-ICLC (Hiltonol)], Durvalumab, Tremelimumab Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors NCT06975410Phase 1, Phase 24 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Seoul Yuhan Corporation ยท Tests: YH32364 Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors NCT04900818Phase 121 sites๐Ÿ“ Orange๐Ÿ“ Aurora๐Ÿ“ Layfayette I-Mab Biopharma US Limited ยท Tests: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (โ€ฆ A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain NCT07326137n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: First-Line Systemic Therapy, Celiac Plexus Neurolysis (CPN) In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers NCT07206355n/a1 site๐Ÿ“ Nottingham University of Nottingham Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC NCT05733598Phase 212 sites๐Ÿ“ Beverly Hills๐Ÿ“ La Jolla๐Ÿ“ Miami Replimune, Inc. ยท Tests: RP2, Bevacizumab, Atezolizumab, Durvalumab, RP2 Monotherapy GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment ๏ผˆBTC-IM-1๏ผ‰ NCT06988592n/a1 site๐Ÿ“ Shanghai Fudan University ยท Tests: GemCis plus PD-1/PD-L1 inhibitor Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer NCT07710885Phase 321 sites๐Ÿ“ Brisbane๐Ÿ“ Melbourne๐Ÿ“ Perth Taiho Pharmaceutical Co., Ltd. ยท Tests: Futibatinib, Zimberelimab, Durvalumab, Pembrolizumab, Gemcitabine CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence NCT06037980Phase 2, Phase 319 sites๐Ÿ“ Ancona๐Ÿ“ Bergamo๐Ÿ“ Bologna Gruppo Oncologico del Nord-Ovest ยท Tests: Gemcitabine, Nab paclitaxel, Cisplatin, Curative Surgery, Capecitabine A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer NCT07850791Phase 21 site๐Ÿ“ Beijing Haitao Zhao, MD ยท Tests: Sacituzumab Tirumotecan (SKB264), Pembrolizumab Phase II Study of Primary Tumor Resection and Selective Lymph Node Dissection Followed by RT for BTC With Lymph Node Metastases NCT07893392Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Primary Tumor Resection and Selective Lymph Node Dissection, Postoperative Radiotherapy, Capecitabine or S-1 Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer NCT07159204Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Paclitaxel polymer micelle immunocombination A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites๐Ÿ“ Duarte๐Ÿ“ Newport Beach๐Ÿ“ Boston SEED Therapeutics, Inc. ยท Tests: ST-01156 HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer NCT07466238NA2 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University ยท Tests: HAIC(GOLF), Bevacizumab, PD-1/PD-L1 inhibitor, HAIC (FOLFOX), Gemcitabin A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer NCT07619235Phase 41 site๐Ÿ“ Wuhan Xianglin Yuan ยท Tests: Iparomlimab and Toripalimab, Bevacizumab, Gemcitabine (1000 mg/m2), Cisplatin SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites๐Ÿ“ Glen Burnie๐Ÿ“ Pittsburgh๐Ÿ“ Seoul SK Life Science, Inc. ยท Tests: SKL35501, SKL35502 A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer NCT07265674Phase 318 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Santa Monica J-Pharma Co., Ltd. ยท Tests: Nanvuranlat, Physician's Best Choice Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical Trial NCT07609641NA1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: surgery A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Fort Myers Bayer ยท Tests: BAY2927088 D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer NCT06622057Phase 34 sites๐Ÿ“ Tucson๐Ÿ“ Miami Beach๐Ÿ“ Cleveland InnoPharmax Inc. ยท Tests: D07001-Softgel Capsules, Placebo, Capecitabine AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) NCT07038343Phase 1, Phase 227 sites๐Ÿ“ Gilbert๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Avenzo Therapeutics, Inc. ยท Tests: AVZO-1418, Combination Agent 1, Combination Agent 2 ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer NCT07151118n/a1 site๐Ÿ“ Seongnam-si CHA University ยท Tests: Blood Sampling for ctDNA Analysis Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) NCT07433673Phase 21 site๐Ÿ“ New York Columbia University ยท Tests: Cemiplimab A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221Phase 1, Phase 220 sites๐Ÿ“ Los Angeles๐Ÿ“ Baltimore๐Ÿ“ Boston Verastem, Inc. ยท Tests: VS-7375, Cetuximab, Carboplatin + Pemetrexed + Pembrolizumab, Gemcitabine + Nab-paclitaxel, Pembrolizumab Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Denver Phanes Therapeutics ยท Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDAยฎ (pembrolizumab) YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies NCT07763301Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: YMN-136 vaccine Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors NCT07726446Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: PD-1 and chemotherapy, cryoablation Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer NCT06467357Phase 3272 sites๐Ÿ“ Scottsdale๐Ÿ“ Tucson๐Ÿ“ Tucson AstraZeneca ยท Tests: Gemcitabine, Cisplatin, Durvalumab, Trastuzumab deruxtecan, Rilvegostomig A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) NCT07229625Phase 31 site๐Ÿ“ Hangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-8068 Injection, Adebrelimab Injection, Gemcitabine Hydrochloride for Injection, Cisplatin Injection, Durvalumab Injโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy